drugset / Trial / NCT02104297

Effect of Deksmedetomidine and Remifentanil in Extubation Agitation

NCT02104297

RandomizedParallel-groupTriple-blindPrevention

Summary

To compare the effect of two different agents deksmedetomidine, remifentanil and placebo, agitation and recovery condition, on nasal septum operation.

Timeline

Start
2014-04
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.2 ug/kg
Subject Remifentanil Small molecule 0.2 ug/kg

Indications

No indication recorded.